AU2001275414A1 - Method for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents

Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Info

Publication number
AU2001275414A1
AU2001275414A1 AU2001275414A AU7541401A AU2001275414A1 AU 2001275414 A1 AU2001275414 A1 AU 2001275414A1 AU 2001275414 A AU2001275414 A AU 2001275414A AU 7541401 A AU7541401 A AU 7541401A AU 2001275414 A1 AU2001275414 A1 AU 2001275414A1
Authority
AU
Australia
Prior art keywords
prevention
reduction
events associated
cardiovascular events
coronary intervention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275414A
Inventor
John M. Baldoni
Albert Kearney
Robin S Roman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001275414A1 publication Critical patent/AU2001275414A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001275414A 2000-06-16 2001-06-08 Method for the prevention or reduction of cardiovascular events associated with coronary intervention Abandoned AU2001275414A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21214800P 2000-06-16 2000-06-16
US60212148 2000-06-16
US22388000P 2000-08-08 2000-08-08
US60223880 2000-08-08
PCT/US2001/018632 WO2001097798A1 (en) 2000-06-16 2001-06-08 Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Publications (1)

Publication Number Publication Date
AU2001275414A1 true AU2001275414A1 (en) 2002-01-02

Family

ID=26906820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275414A Abandoned AU2001275414A1 (en) 2000-06-16 2001-06-08 Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Country Status (2)

Country Link
AU (1) AU2001275414A1 (en)
WO (1) WO2001097798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097650B2 (en) 2005-07-27 2012-01-17 The Trustees Of Columbia University In The City Of New York Method of treating a condition associated with phosphorylation of TASK-1
WO2008013988A2 (en) * 2006-07-27 2008-01-31 The Trustees Of Columbia University In The City Of New York Method of treating a condition associated with phosphorylation of task-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046239A (en) * 1997-08-05 2000-04-04 American Home Products Corporation Anthranilic acid analogs

Also Published As

Publication number Publication date
WO2001097798A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2002246775A1 (en) Coronary guidewire system
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU2002224407A1 (en) Composite guidewire
AU2002334881A1 (en) Composite guidewire
AU2002213831A1 (en) Actuating member and method for producing the same
AU1935600A (en) Free form furniture
AU5294100A (en) Method and compositions for treating the inflammatory response
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
AU2001257075A1 (en) Screen and method of making the same
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU2001218494A1 (en) Resolution of the enantiomers of amlodipine
AU6337700A (en) Method for the decontamination of metallic surfaces
EP1405912B8 (en) Genetically modified ecarin and process for producing the same
AU2001280270A1 (en) Method of manufacturing structural members and the members provided by such method
AU5057600A (en) Component and method for the production thereof
AU2001272368A1 (en) Method for the preparation of citalopram
AU2002229549A1 (en) Composite metal panel
AU2001268163A1 (en) Haplotypes of the ube3a gene
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2001228628A1 (en) Stent-graft assembly and method of making the same
AU2001275414A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2000244990A1 (en) Footwear structure and method of forming the same
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
IL144719A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001220572A1 (en) Composite guidewire